Retinal atrophy, inflammation, phagocytic and metabolic disruptions develop in the MerTK-cleavage-resistant mouse model.

Autor: Enderlin J; INSERM, CNRS, Institut de la Vision, Therapeutics Department, Sorbonne Université, Paris, France., Rieu Q; INSERM, CNRS, Institut de la Vision, Therapeutics Department, Sorbonne Université, Paris, France., Réty S; INSERM, CNRS, Institut de la Vision, Therapeutics Department, Sorbonne Université, Paris, France., Vanoni EM; INSERM, CNRS, Institut de la Vision, Therapeutics Department, Sorbonne Université, Paris, France., Roux S; INSERM, CNRS, Institut de la Vision, Therapeutics Department, Sorbonne Université, Paris, France., Dégardin J; INSERM, CNRS, Institut de la Vision, Therapeutics Department, Sorbonne Université, Paris, France., César Q; INSERM, CNRS, Institut de la Vision, Therapeutics Department, Sorbonne Université, Paris, France., Augustin S; INSERM, CNRS, Institut de la Vision, Therapeutics Department, Sorbonne Université, Paris, France., Nous C; INSERM, CNRS, Institut de la Vision, Therapeutics Department, Sorbonne Université, Paris, France., Cai B; Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Fontaine V; INSERM, CNRS, Institut de la Vision, Therapeutics Department, Sorbonne Université, Paris, France., Sennlaub F; INSERM, CNRS, Institut de la Vision, Therapeutics Department, Sorbonne Université, Paris, France., Nandrot EF; INSERM, CNRS, Institut de la Vision, Therapeutics Department, Sorbonne Université, Paris, France.

Publikováno v: Frontiers in neuroscience [Front Neurosci] 2024 Apr 12; Vol. 18, pp. 1256522. Date of Electronic Publication: 2024 Apr 12 (Print Publication: 2024).